Norges Bank
IRMD icon

Norges Bank’s iRadimed IRMD Stock Holding History

Norges Bank’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Buy
+50,600
New +$4.61M ﹤0.01% 1391
2024
Q3 		– Sell
-16,500
Closed -$725K – 1900
2024
Q2 		$725K Buy
+16,500
New +$702K ﹤0.01% 1848

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank's IRMD Position: Q2 2026 in Review

Norges Bank opened a new position in iRadimed (IRMD) in Q2 2026: 50,600 shares worth $4.84M. The stake represents ﹤0.01% of the portfolio and ranks #1391 among its holdings. This is a return to the name: Norges Bank previously reported a position in IRMD as recently as Q2 2024.

Norges Bank first reported a position in IRMD in Q2 2024 and has held it in 2 quarters since. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Norges Bank held 50,600 shares of iRadimed worth $4.84M as of Q2 2026.
  • iRadimed was a new Norges Bank position in Q2 2026.
  • iRadimed made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1391 holding.
  • Norges Bank first reported a position in iRadimed in Q2 2024 and has held it in 2 quarters since.
  • 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.